Excelsior Advisor Network’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10M Buy
39,935
+35,260
+754% +$7.59M 1.32% 10
2026
Q1
$1.02M Buy
4,675
+1,284
+38% +$285K 0.39% 63
2025
Q4
$775K Buy
+3,391
New +$772K 0.38% 66

Other funds holding ABBV

Excelsior Advisor Network's ABBV Position: Q2 2026 in Review

Excelsior Advisor Network increased its AbbVie (ABBV) stake by 754% in Q2 2026, buying an estimated $7.59M and bringing the position to 39,935 shares worth $10M. The position accounts for 1.32% of the portfolio, ranked #10.

Excelsior Advisor Network first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Excelsior Advisor Network held 39,935 shares of AbbVie worth $10M as of Q2 2026.
  • Excelsior Advisor Network bought 35,260 AbbVie shares in Q2 2026, an estimated $7.59M.
  • AbbVie made up 1.32% of Excelsior Advisor Network's portfolio in Q2 2026, its #10 holding.
  • Excelsior Advisor Network first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Excelsior Advisor Network's 13F filing for Q2 2026, filed 14 Aug 2026.